Elon Musk's social media platform temporarily made information about its users' localizations public, sparking the rumor ...
How Analyst Views Are Shifting the Ascendis Pharma Story After Recent Yorvipath and Pipeline Updates
Ascendis Pharma stock has seen its fair value estimate trimmed slightly from $258.77 to $257.66, based on a nuanced shift in analyst expectations. The discount rate increased from 6.77% to 6.81%, ...
Government also confirms end of 5p fuel duty freeze, a change to luxury car tax and review of EV charging prices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results